The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the […]

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN. LONDON,

LONDON, UK / ACCESS Newswire / February 23, 2026 / The Company announces that on 20 February 2026 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company’s Annual General Meeting on

M31 Technology (M31), a global leader in silicon intellectual property (IP), today announced that the silicon-proven MIPI M-PHY v5.0 IP has been validated on an advanced 4nm process node and is actively advancing development toward the 3nm node. This milestone demonstrates M31’s core technical capability to enable UFS 4.1 (Universal Flash Storage) through a comprehensive

The DJS Law Group reminds investors of a class action lawsuit against uniQure N.V. (“uniQure ” or “the Company”) (NASDAQ: QURE ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of QURE during the

Total consideration adjusted to £1.325 billion, long stop date extended to accommodate outstanding transaction requirements Honeywell (NASDAQ: HON) today announced that it has entered into an amended agreement to acquire Johnson Matthey’s Catalyst Technologies business segment, which adjusts the total consideration from £1.8 billion to £1.325 billion and extends the long stop date to July

Gemtek today unveiled its next-generation broadband strategy centered on Wi-Fi 8, positioning the new standard as a foundational technology for AI-driven, service-oriented networks. The announcement underscores Gemtek’s commitment to supporting service providers as the industry transitions from bandwidth-focused connectivity to intelligent, experience-driven networking. Under the theme “From Speed to Intelligence,” Gemtek demonstrated the integration of

(TSX-V:PLSR),(OTC US:PSRHF),(Other OTC:PSRHF),(LSE – AIM:PLSR), THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT

MUTTENZ, Switzerland, Feb. 23, 2026 (GLOBE NEWSWIRE) — Opterion Health AG today announced that the first patient has been successfully enrolled in its Phase 1 SPARC trial. This marks the official start of the company's first-in-human clinical development program for OPT101, its non-glucose-based osmotic agent designed to transform peritoneal dialysis (PD). This milestone follows the

Opterion Health AG Announces First Patient enrolled in Phase 1 SPARC Trial Following CTA Approval for OPT101 GlobeNewswire February 23, 2026 MUTTENZ, Switzerland, Feb. 23, 2026 (GLOBE NEWSWIRE) — Opterion Health AG today announced that the first patient has been successfully enrolled in its Phase 1 SPARC trial. This marks the official start of the